Cellectra™ Human CD8 NanoSort Microbeads, Research grade

This product is compatible with mainstream automated cell processing instruments and commercially available column-based (M/D/L) magnetic separation systems.

• High Safety
  • Raw Material Safety: The conjugated antibodies are recombinant antibodies, avoiding contamination from animal-derived viruses and exogenous factor pollutants. Medical-grade nanoparticles with dextran matrix coating - high biocompatibility, biodegradable.
  • Supply Chain Safety: Highly integrated autonomous platforms for nano-magnetic beads and single B-cell antibody.
  • Process Safety : AOF production process prevents exogenous factor contamination, with rigorous quality control ensuring product safety.
• High Sorting Purity
  • Conjugated antibodies are derived from a single B-cell antibody development platform, featuring optimized antibody epitopes.
  • Nanoscale superparamagnetic beads enable efficient and gentle cell sorting.
• Long-Term Stability
  • Stable for 24 months at -20 °C or below.

Cellectra™ Human CD8 NanoSort Microbeads are dextran-coated superparamagnetic nanoparticles conjugated with recombinant monoclonal antibodies specific to human CD8. They are especially designed for positive or negative selection of CD8+ cells.
The beads are manufactured under sterile ISO 5 conditions with no animal- or human-derived components. Each batch undergoes rigorous quality control, including sterility, endotoxin, and functional validation.

Cellectra™ Human CD8 NanoSort Microbeads are designed for the positive selection or negative selection of human cytotoxic CD8+ T cells from fresh or frozen human peripheral blood mononuclear cells (PBMCs). The CD8 antigen forms a complex together with the T cell receptor and acts as an accessory molecule in the recognition of MHC class I/peptide complexes by the TCR heterodimer on CD8+ cytotoxic T cells. It is predominantly expressed on the surface of cytotoxic T cells. The magnetic nBeads are conjugated with monoclonal antibodies targeting human CD8 protein, enabling CD8+ cells to be labeled with the specific antibodies and magnetic particles, and separated using the separation columns and magnets.

For long term storage, the product should be stored in liquid state at -20°C or below. Stability upon receipt: Stable for 24 months at -20 °C or below; Stable for 9 months at 2-8 °C under sterile conditions.

Please protect from light and avoid repeated freeze-thaw cycles.

Negative

Less than 2 EU per mL by the LAL method / rFC method.

Negative

This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

Supplied in PBS buffer containing EDTA, rHSA and Poloxamer 188.